Study of Phenobarbital Inhibition of Catamenial Epilepsy

Summary

The purpose of this study is to test the effectiveness of low-dose Phenobarbital on the treatment of catamenial epilepsy. We propose that since the catamenial seizures are associated with the reduction in levels of GABA-enhancing allopregnanolone, short-term replacement with the GABAR-enhancing agent Phenobarbital will reduce the incidence of catamenial seizures.

Timeline

Start

2007-03

Primary completion

2009-03

Completion

—

Drugs

Indications